Presentations 2021

The Liver Meeting® 2021 - The 72nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Anaheim, CA, United States, 12-15 November 2021

Poster presentations:
Real-world effectiveness and factors associated with SVR12 in a diverse population of HCV infected persons from four large European cohorts presented by Lars Peters. POSTER


18th European AIDS Conference (EACS), October 27-30, 2021, London, United Kingdom

Recent Abacavir Use and Incident Cardiovascular Disease in Contemporary Treated PLWH within the RESPOND Cohort Consortium  presented by Nadine Josephine Jaschinski on behalf of the RESPOND study group. PRESENTATION

Large inter-country and intra-country differences in the HCV cascades of care in people living with HIV in Russia and Ukraine presented by Olga Fursa. Best Poster presentation.  PRESENTATION

Poster presentations:
The association between hepatitis B infection and malignancies in persons living with HIV: results from the EuroSIDA study presented by Amanda Mocroft on behalf of EuroSIDA Study Group. POSTER

Incidence of hypertension in people living with HIV receiving InSTI versus other third-drug ART regimens in the RESPOND cohort presented by Dathan Mirembe Byonanebye on behalf of RESPOND Study Group. POSTER

HIV cascade of care in the Eastern European cohort (CARE cohort: Russia, Ukraine, Georgia) presented by Olga Fursa. POSTER


11th IAS Conference on HIV Science, 18-21 July 2021

Co-morbidities In People Living With HIV: Host- Or HIVAssociated presented by Lene Ryom MD PhD. PRESENTATION

Poster presentations:
Integrase strand transfer inhibitor (INSTI) use and cancer incidence presented by Lauren Greenberg on behalf of the RESPOND Study Group. POSTER


Conference on Retroviruses and Opportunistic Infections, Virtual, 6-10 March 2021

Pre-recorded presentations:
Association between newer antiretrovirals and increase in body mass index RESPOND presented by Loveleen Bansi-Matharu on behalf of the RESPOND Study Group. PRESENTATION

Association between integrase inhibitors (INSTIs) and cardiovascular disease (CVD) presented by Bastian Neesgaard on behalf of the RESPOND Study Group. PRESENTATION

Hepatitis C cascade of care in HIV/HCV-coinfected persons in Europe in the DAA era presented by Olga Fursa on behalf of the EuroSIDA Study Group. PRESENTATION

Hepatitis delta-related disease burden in HIV/HBV coinfected presented by Charles Béguelin on behalf of the EuroSIDA Study Group and the Swiss HIV Cohort Study. PRESENTATION